151 related articles for article (PubMed ID: 33813284)
1. Comparison of inner ear MRI enhancement in patients with Meniere's disease after intravenous injection of gadobutrol, gadoterate meglumine, or gadodiamide.
Xie J; Zhang W; Zhu J; Hui L; Li S; Zhang B
Eur J Radiol; 2021 Jun; 139():109682. PubMed ID: 33813284
[TBL] [Abstract][Full Text] [Related]
2. Comparison of enhancement of the vestibular perilymph between gadoterate meglumine and gadobutrol at 3-Tesla in Meniere's disease.
Eliezer M; Poillon G; Gillibert A; Horion J; Cruypeninck Y; Gerardin E; Magne N; Attyé A
Diagn Interv Imaging; 2018 May; 99(5):271-277. PubMed ID: 29398574
[TBL] [Abstract][Full Text] [Related]
3. Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
McDonald JS; Hunt CH; Kolbe AB; Schmitz JJ; Hartman RP; Maddox DE; Kallmes DF; McDonald RJ
Radiology; 2019 Sep; 292(3):620-627. PubMed ID: 31264948
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T.
Attenberger UI; Runge VM; Morelli JN; Williams J; Jackson CB; Michaely HJ
J Magn Reson Imaging; 2010 Mar; 31(3):549-55. PubMed ID: 20187196
[TBL] [Abstract][Full Text] [Related]
5. A Structured Survey on Adverse Events Occurring Within 24 Hours After Intravenous Exposure to Gadodiamide or Gadoterate Meglumine: A Controlled Prospective Comparison Study.
Parillo M; Sapienza M; Arpaia F; Magnani F; Mallio CA; DʼAlessio P; Quattrocchi CC
Invest Radiol; 2019 Apr; 54(4):191-197. PubMed ID: 30379729
[TBL] [Abstract][Full Text] [Related]
6. [Visualization of endolymphatic hydrops in 3D-FLAIR MRI after intratympanic Gd-DTPA administration in Meniere's disease patients].
Zhang DG; Shi HL; Fan ZM; Wang GB; Han YC; Li YW; Wang HB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Aug; 48(8):628-33. PubMed ID: 24195817
[TBL] [Abstract][Full Text] [Related]
7. T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
Robert P; Lehericy S; Grand S; Violas X; Fretellier N; Idée JM; Ballet S; Corot C
Invest Radiol; 2015 Aug; 50(8):473-80. PubMed ID: 26107651
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
[TBL] [Abstract][Full Text] [Related]
9. Ultra-high-field (9.4 T) MRI Analysis of Contrast Agent Transport Across the Blood-Perilymph Barrier and Intrastrial Fluid-Blood Barrier in the Mouse Inner Ear.
Counter SA; Nikkhou-Aski S; Damberg P; Berglin CE; Laurell G
Otol Neurotol; 2017 Aug; 38(7):1052-1059. PubMed ID: 28570419
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.
Lee CH; Vellayappan B; Taupitz M; Hamm B; Asbach P
Eur Radiol; 2019 Dec; 29(12):6982-6990. PubMed ID: 31264013
[TBL] [Abstract][Full Text] [Related]
11. MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.
Saake M; Langner S; Schwenke C; Weibart M; Jansen O; Hosten N; Doerfler A
Eur Radiol; 2016 Mar; 26(3):820-8. PubMed ID: 26123410
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.
Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C
Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151
[TBL] [Abstract][Full Text] [Related]
13. Inner ear MRI enhancement based on three dimensional-real IR sequence in patients with Meniere's disease after intravenous gadolinium injection: Comparison of different doses used and exploration of an appropriate dose.
Chen W; Geng Y; Niu Y; Lin N; Wang X; Sha Y
Clin Otolaryngol; 2022 Nov; 47(6):717-723. PubMed ID: 35034431
[TBL] [Abstract][Full Text] [Related]
14. The effect of delay time after injecting gadobutrol on the diagnosis of endolymphatic hydrops.
Zhang W; Xie J; Wang M
Magn Reson Imaging; 2024 Apr; 107():160-163. PubMed ID: 38176577
[TBL] [Abstract][Full Text] [Related]
15. Differences in perilymphatic space enhancement and adverse inflammatory reaction after intratympanic injection of two different gadolinium agents: A 9.4-T magnetic resonance imaging study.
Park M; Lee HS; Kim H; Oh SH; Lee JH; Suh MW
Hear Res; 2016 Mar; 333():118-126. PubMed ID: 26795351
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Gadoterate Meglumine and Gadobutrol in the MRI Diagnosis of Primary Brain Tumors: A Double-Blind Randomized Controlled Intraindividual Crossover Study (the REMIND Study).
Maravilla KR; San-Juan D; Kim SJ; Elizondo-Riojas G; Fink JR; Escobar W; Bag A; Roberts DR; Hao J; Pitrou C; Tsiouris AJ; Herskovits E; Fiebach JB
AJNR Am J Neuroradiol; 2017 Sep; 38(9):1681-1688. PubMed ID: 28663267
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Dynamic Contrast-Enhancement Parameters between Gadobutrol and Gadoterate Meglumine in Posttreatment Glioma: A Prospective Intraindividual Study.
Park JE; Kim JY; Kim HS; Shim WH
AJNR Am J Neuroradiol; 2020 Nov; 41(11):2041-2048. PubMed ID: 33060100
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Speciation Analysis of Residual Gadolinium in Deep Cerebellar Nuclei in Rats Repeatedly Administered With Gadoterate Meglumine or Gadodiamide.
Strzeminska I; Factor C; Jimenez-Lamana J; Lacomme S; Subirana MA; Le Coustumer P; Schaumlöffel D; Robert P; Szpunar J; Corot C; Lobinski R
Invest Radiol; 2022 May; 57(5):283-292. PubMed ID: 35066532
[TBL] [Abstract][Full Text] [Related]
19. MR Angiography at 3 T of Peripheral Arterial Disease: A Randomized Prospective Comparison of Gadoterate Meglumine and Gadobutrol.
Loewe C; Arnaiz J; Krause D; Marti-Bonmati L; Haneder S; Kramer U;
AJR Am J Roentgenol; 2015 Jun; 204(6):1311-21. PubMed ID: 26001243
[TBL] [Abstract][Full Text] [Related]
20. Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.
Robert P; Vives V; Grindel AL; Kremer S; Bierry G; Louin G; Ballet S; Corot C
Radiology; 2020 Jan; 294(1):117-126. PubMed ID: 31660804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
